Literature DB >> 16937474

Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: a case-control study.

Eskandar Hajiani1, Jalal Hashemi, Rahim Masjedizadeh, Ali Akbar Shayesteh, Esmail Idani, Tahereh Rajabi.   

Abstract

AIM: To evaluate possible risk factors for the spread of hepatitis C infection and to analyze the characteristics of the epidemiological and clinical patterns among the patients with hepatitis C infection.
METHODS: During a five-year period a cross-sectional study was conducted among HCV positive individuals referred to the Ahwaz JundiShapour University Hospitals (AJSUH) and Hepatitis Clinic from 1 Sept 1999 to 1 Sept 2003. The control group consisted of first time blood donors referred to the Regional Blood Transfusion organization. Enzyme-linked immunosorbent assay and recombinant immunoblot assay anti-hepatitis C virus (HCV) tests were performed for two groups. Positive serum specimens were retested using polymerase chain reaction (PCR) for HCV RNA. Risk factors were evaluated using a questionnaire. Reported risk factors among infected subjects ("HCV-positive") were compared to those of subjects never exposed ("HCV-negative") to HCV.
RESULTS: A total of 514 subjects were studied for HCV, of which 254 were HCV-positive and 260 HCV-negative donors comprised the control group. Mean age of the patients was 28.4 (Std 15.22) years. HCV-positive subjects were more likely to be of male gender (63% versus 37%). Transfusion 132 (52%), non-intravenous (n-i.v.) drug abuse and i.v. drug abuse 37 (14.5%), haemodialysis 25 (10%), receiving wounds at war and extramarital sexual activities (2.4%), tattooing (3.6%) were found to be independent risk factors of being HCV-positive. No apparent risk factors could be demonstrated in 29 (11.2%) of the positive cases.
CONCLUSION: Our data indicate that a history of transfusion and i.v. drug abuse and haemodialysis are important risk factors for HCV infection in our area and that more careful pretransfusion screening of blood for anti-HCV must be introduced in our blood banks. Improvements in certain lifestyle patterns, and customs in this area may be essential to prevent transmission of the infection.

Entities:  

Mesh:

Year:  2006        PMID: 16937474      PMCID: PMC4087626          DOI: 10.3748/wjg.v12.i30.4884

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  GBV-C infection among patients with hepatitis C virus in the Islamic Republic of Iran: a preliminary report.

Authors:  M R Zali; M Mayumi; M Raoufi; A Nowroozi
Journal:  East Mediterr Health J       Date:  1999-09       Impact factor: 1.628

2.  Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study.

Authors:  Seyed Moayed Alavian; Bardia Gholami; Sadegh Masarrat
Journal:  J Gastroenterol Hepatol       Date:  2002-10       Impact factor: 4.029

3.  Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility.

Authors:  Alan Neaigus; V Anna Gyarmathy; Maureen Miller; Veronica M Frajzyngier; Samuel R Friedman; Don C Des Jarlais
Journal:  J Acquir Immune Defic Syndr       Date:  2006-04-01       Impact factor: 3.731

Review 4.  Hepatitis C: the clinical spectrum of the disease.

Authors:  P Marcellin
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

5.  Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors.

Authors:  A Neaigus; M Miller; S R Friedman; D L Hagen; S J Sifaneck; G Ildefonso; D C des Jarlais
Journal:  Addiction       Date:  2001-06       Impact factor: 6.526

6.  Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection.

Authors:  P A Tovo; L J Pembrey; M L Newell
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

Review 7.  Epidemiology of hepatitis C: geographic differences and temporal trends.

Authors:  A Wasley; M J Alter
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

8.  Mosquito cells bind and replicate hepatitis C virus.

Authors:  R Germi; J M Crance; D Garin; J Guimet; M A Thelu; A Jouan; J P Zarski; E Drouet
Journal:  J Med Virol       Date:  2001-05       Impact factor: 2.327

9.  Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients.

Authors:  H Hinrichsen; G Leimenstoll; G Stegen; H Schrader; U R Fölsch; W E Schmidt
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

10.  Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran.

Authors:  A A Ghavanini; M R Sabri
Journal:  East Mediterr Health J       Date:  2000 Sep-Nov       Impact factor: 1.628

View more
  6 in total

Review 1.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  Population-attributable estimates for risk factors associated with hepatitis B and C: policy implications for Pakistan and other South Asian countries.

Authors:  Bilal Ahmed; Tooba Ali; Huma Qureshi; Saeed Hamid
Journal:  Hepatol Int       Date:  2013-01-10       Impact factor: 6.047

3.  Identification of HCV genotypes in HCV infected blood donors.

Authors:  Zohreh Sharifi; Mahmood Mahmoodian Shooshtari; Fahimeh Rangbar Kermani
Journal:  Indian J Microbiol       Date:  2010-10-30       Impact factor: 2.461

4.  Prevalence of HCV Infections and Co-Infection With HBV and HIV and Associated Risk Factors Among Addicts in Drug Treatment Centers, Lorestan Province, Iran.

Authors:  Hossein Norouzian; Mohammadreza Gholami; Pegah Shakib; Gholamreza Goudarzi; Hamze Ghobadian Diali; Azam Rezvani
Journal:  Int J High Risk Behav Addict       Date:  2016-01-18

5.  Injection drug use is a risk factor for HCV infection in urban Egypt.

Authors:  Adela Paez Jimenez; Mostafa K Mohamed; Noha Sharaf Eldin; Hasnaa Abou Seif; Said El Aidi; Yehia Sultan; Nasr Elsaid; Claire Rekacewicz; Mostafa El-Hoseiny; May El-Daly; Mohamed Abdel-Hamid; Arnaud Fontanet
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

6.  Prevalence of hepatitis B and C infections and HCV genotypes among haemophilia patients in ahvaz, southwest iran.

Authors:  Mohammad Ali Assarehzadegan; Mehri Ghafourian Boroujerdnia; Khodamorad Zandian
Journal:  Iran Red Crescent Med J       Date:  2012-08-30       Impact factor: 0.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.